Hypertension Clinical Trial
Official title:
Cardiovascular Risk Disparities: Socio-Emotional Pathways
Cardiovascular disease (CVD) is the leading cause of death in American women, claiming on average 40% of all female deaths each year. Although the number of CVD-related deaths in the United States has decreased over the last several decades, the rate of decline has been less for women than for men. Specifically, minority women of low socioeconomic status make up a disproportionately high number of CVD cases and related deaths. Previous studies suggest that, in addition to many other variables, psychosocial variables may contribute to ethnic CVD disparities. More research, however, is needed to help understand and reduce these differences. This study will examine the associations among socioeconomic status, psychological and social factors, CVD biomarkers, and CVD in Mexican-American women.
One in four women in the United States has some form of CVD, which includes heart disease,
high blood pressure, and heart attack. Minority and low socioeconomic status populations
show particularly disproportionate rates of CVD morbidity and mortality. Previous research
suggests that individuals with lower social status may suffer negative emotional and
physical health consequences due to increased stress experienced across multiple areas of
life. It is believed that stress may directly affect behavioral, physiological, and
emotional risk processes, which have all been linked to increased CVD risk. In addition,
people with low socioeconomic status are often less capable of seeking psychosocial
resources with which to manage stress, making them especially vulnerable to the associated
physical and emotional wear and tear. More information is needed on the effects of
psychosocial variables on the cardiovascular health of minority, specifically
Mexican-American, women. This study will examine the associations among socioeconomic
status, psychological and social factors, CVD biomarkers, and CVD in Mexican-American women.
Participation in this study will involve two home visits, with total participation time
lasting about 6 hours. During the first study visit, participants will complete a variety of
questionnaires on stressful experiences, social relationships, background and culture,
thoughts and emotions, health habits, and medical history. Participants will also have their
blood pressure measured and will be given a container and instructions to perform a 12-hour
overnight urine collection.
During the second study visit, occurring a couple of days after the first visit,
participants will undergo a blood draw, physical and vital sign measurements, and a training
session on how to use an ambulatory blood pressure monitor and handheld computer diary.
Participants who fit properly into the arm cuff of the ambulatory blood pressure monitor
will then be asked to wear the monitor for 36 hours. Every time the monitor records a blood
pressure reading, participants will be asked to use their handheld computer diary and answer
questions about temperature, exercise, posture, stress, mood, and social interactions. There
will be a total of 52 to 56 diary entries, taking between 2 and 3 minutes to complete each
entry. Within 1 month, participants will receive a letter summarizing their health profile
in terms of weight, cholesterol levels, and blood glucose. Participants will also be
provided with information on seeking appropriate treatments for any health problems
discovered on their profile.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |